Wednesday, October 15, 2025

Latest

A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley – Cardiol Therapeutics

FULL DISCLOSURE: This is sponsored content for Cardiol Therapeutics.

Discover the major breakthrough at Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) as CEO David Elsley reveals the enrollment of their first patient in the pivotal Phase 3 MAVERIC trial for recurrent pericarditis. In this concise interview, Elsley discusses how their oral drug therapy aims to prevent new episodes of this debilitating heart condition, the impressive Phase 2 results showing significant pain reduction, and the potential timeline for market entry by mid-2026.

With trial sites at prestigious institutions like Mass General, Cleveland Clinic, and Mayo Clinic, and a market potential approaching $1 billion by 2028, investors won’t want to miss this significant development in cardiovascular medicine.


FULL DISCLOSURE: Cardiol Therapeutics is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of Cardiol Therapeutics. The author has been compensated to cover Cardiol Therapeutics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Military Seizes Power in Madagascar After President Flees

Altamira Gold Hits 395.5 Metres Of 0.4 g/t Gold At Maria Bonita

Related News

Doug Hurst: The Fed Is Done Raising Rates

Today on the Daily Dive, we sit down with Doug Hurst, Chairman of Elevation Gold...

Wednesday, March 29, 2023, 01:30:00 PM

The Next Big Catalyst for Gold — With Doug Casey

Returning to the Daily Dive is Doug Casey, a world-renowned resource speaker, New York Times...

Wednesday, March 15, 2023, 01:30:00 PM

Cannabis Has Contributed $43.5 Billion To Canadian GDP – The Daily Dive

Returning to the Daily Dive today is Emily Paxhia, co-founder and Managing Partner of Poseidon...

Thursday, February 17, 2022, 01:30:00 PM

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Cardiol Therapeutics (TSX: CRDL) (NYSE: CRDL) has released topline results from their phase two ARCHER...
Thursday, August 7, 2025, 11:28:24 AM

Michael Gentile: The Fed Wants Inflation To Be Very High – The Daily Dive

For our mid-week episode of the Daily Dive, we sit down with Michael Gentile, a...

Wednesday, June 16, 2021, 02:00:00 PM